The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation

This publication has 30 references indexed in Scilit:

• PD-L1/B7H-1 Inhibits the Effector Phase of Tumor Rejection by T Cell Receptor (TCR) Transgenic CD8+ T Cells
  Cancer Research, 2004
• Novel systemic therapies for breast cancer
  Surgical Oncology, 2003
• Carcinoma of the ovary
  International Journal of Gynecology & Obstetrics, 2003
• Regulation of PD‐1, PD‐L1, and PD‐L2 expression during normal and autoimmune responses
  European Journal of Immunology, 2003
• Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling
  Nature Reviews Immunology, 2003
• BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1
  Nature Immunology, 2003
• RNA interference
  Nature, 2002
• The B7 Family of Ligands and Its Receptors: New Pathways for Costimulation and Inhibition of Immune Responses
  Annual Review of Immunology, 2002
• Survival of Patients with Epithelial Ovarian Cancer and the Effect of Lymphadenectomy in Those with Stage 3 Disease
  Australian and New Zealand Journal of Obstetrics and Gynaecology, 1999
• Targeted Eradication of Ovarian Cancer Mediated by Intracellular Expression of Anti-erbB-2 Single-Chain Antibody
  Gynecologic Oncology, 1995